top of page
Xsome Slider Photo.jpg

The next big thing 

comes in small packages

Xsome Biotech is a clinical stage company pioneering exosome therapeutics 

ABOUT US

Founded in 2021 by Dr. Ke Cheng, Xsome Biotech has licensed key IPs from North Carolina State University. Xsome Biotech seeks to develop exosome therapeutics and novel drug delivery carriers for a variety of diseases. The company is a lead candidate (XO101 lung stem cell based secretome) and has gained IND approval for treating patients with ARDS. 

OUR SCIENCE

Xsome Biotech's ResEV platform technology allows precise delivery of drugs to the lung paranchyma via inhalation. There are several fold of enhancement when compared to liposomes. We have also pioneered the use of EVs for lung regeneration.

CONTACT US

Thanks for submitting!

Xsome Biotech Options-02.png

Xsome Biotech, Inc

1001 William Moore Drive
Raleigh NC 27606


info@xsomebio.com

Copyright © 2022 Xsome Biotech, Inc

bottom of page